We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$782M
AUM Growth
+$192M
Cap. Flow
+$233M
Cap. Flow %
29.84%
Top 10 Hldgs %
65.23%
Holding
93
New
24
Increased
13
Reduced
10
Closed
33

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$28.9M
2
ELV icon
Elevance Health
ELV
+$19.6M
3
BWXT icon
BWX Technologies
BWXT
+$18.1M
4
EW icon
Edwards Lifesciences
EW
+$13.6M
5
FERG icon
Ferguson
FERG
+$12.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$19.8M
2
HUM icon
Humana
HUM
+$19.6M
3
CNC icon
Centene
CNC
+$13.9M
4
BLMN icon
Bloomin' Brands
BLMN
+$11.9M
5
GTLS
Chart Industries
GTLS
+$9.26M

Sector Composition

Rank Sector Weight
1 Healthcare 18.01%
2 Industrials 8.99%
3 Financials 4.7%
4 Consumer Discretionary 3.83%
5 Technology 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPIC
51
CALL
DELISTED
TPI Composites
TPIC
$1.69M 0.22%
+150,000
New +$2.37M
NVNO
52
enVVeno Medical
NVNO
$7.09M
$1.38M 0.18%
6,262
– –
DMYY.U
53
DELISTED
dMY Squared Technology Group Units
DMYY.U
$1M 0.13%
+100,000
New +$1M
RPD icon
54
Rapid7
RPD
$773M
$644K 0.08%
+15,000
New +$926K
VINC
55
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$531K 0.07%
19,250
– –
JSPR icon
56
Jasper Therapeutics
JSPR
$23.6M
$426K 0.05%
54,000
– –
MTEM
57
DELISTED
Molecular Templates, Inc.
MTEM
$396K 0.05%
35,207
– –
AGTC
58
DELISTED
Applied Genetic Technologies Corporation
AGTC
$333K 0.04%
+1,225,000
New +$535K
EUCRW
59
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$2K ﹤0.01%
66,665
– –
MSACW
60
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$1K ﹤0.01%
33,332
– –
ALNY icon
61
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-38,700
Closed -$5.64M
AVD icon
62
American Vanguard Corp
AVD
$68.9M
– –
-201,400
Closed -$4.5M
AXSM icon
63
PUT
Axsome Therapeutics
AXSM
$10.9B
– –
-250,000
Closed -$9.57M
BAC icon
64
Bank of America
BAC
$442B
– –
-175,000
Closed -$5.45M
BAC icon
65
PUT
Bank of America
BAC
$442B
– –
-225,000
Closed -$7M
BLK icon
66
Blackrock
BLK
$176B
– –
-9,000
Closed -$5.48M
BLMN icon
67
Bloomin' Brands
BLMN
$938M
– –
-714,500
Closed -$11.9M
BBBY
68
CALL
Bed Bath & Beyond
BBBY
$442M
– –
-55,000
Closed -$1.25M
CNC icon
69
Centene
CNC
$32.5B
– –
-163,700
Closed -$13.9M
CRL icon
70
Charles River Laboratories
CRL
$12.8B
– –
-38,365
Closed -$8.21M
DIS icon
71
Walt Disney
DIS
$181B
– –
-22,500
Closed -$2.12M
DLTR icon
72
Dollar Tree
DLTR
$25.2B
– –
-26,500
Closed -$4.13M
DXCM icon
73
DexCom
DXCM
$32B
– –
-74,400
Closed -$5.54M
GH icon
74
CALL
Guardant Health
GH
$22.6B
– –
-150,000
Closed -$6.05M
GRFS
75
Grifois
GRFS
$5.4B
– –
-112,490
Closed -$1.34M
1 2
3
4

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Kingdon Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Kingdon Capital Management held 93 positions worth $782M, up 33% from $589M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Kingdon Capital Management deployed $233M of net new capital in Q3 2022, opening 24 new positions and adding to 13 existing holdings. Its largest new stake was Baxter International: 480,500 shares worth $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was RAPT Therapeutics, an estimated $8.22M trimmed.

  • Kingdon Capital Management's largest Q3 2022 buy was Baxter International: 480,500 shares worth $25.9M.
  • Kingdon Capital Management added most to Palo Alto Networks in Q3 2022, an estimated $4.76M increase.
  • Kingdon Capital Management's biggest Q3 2022 reduction was RAPT Therapeutics, cutting an estimated $8.22M.
  • Kingdon Capital Management fully exited Meta Platforms (Facebook) in Q3 2022, selling an estimated $19.8M.
  • Kingdon Capital Management's ten largest holdings make up 65% of its $782M portfolio in Q3 2022.
  • Kingdon Capital Management opened 24 new positions and closed 33 in Q3 2022.
  • Kingdon Capital Management's portfolio value rose 33% quarter-over-quarter to $782M.

Based on Kingdon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.